MCBR has a provision to facilitate Biopharma companies with GMP lab/infra-structure to start MAHE-Pvt. Partnership research unit at MAHE at a very nominal usage fee or potential option to outsource translational research projects to MCBR.

MCBR is at Advanced stage of collaborative discussions with

??????? Stempeutics 中国体育彩票app下载

??????? Curio Biotech, Switzerland

??????? Esco Aster, Singapore

??????? Cipla Ltd

We welcome more collaborative initiative to the companies for developing novel Biotherapeutics products.